Skip to main content

Table 1 Demographic data for each group at baseline

From: Can cardiovascular risk management be improved by shared care with general practice to prevent cognitive decline following stroke/TIA? A feasibility randomised controlled trial (SERVED memory)

   Observation Control Intervention
N   94 36 37
Symptom onset to randomisation (days)   25.7 (20.1) 22.6 (20.9) 17.8 (19.7)
Age (years)   72.1 (10.9) 74.9 (9.2) 75.0 (12.0)
Sex (male)   59 (62.8%) 23 (63.9%) 27 (73.0%)
Ethnicity (White British)   94 (100.0%) 36 (100.0%) 37 (100.0%)
Smoking status Non-smoker 38 (40.4%) 17 (47.2%) 26 (70.3%)
Ex-smoker 29 (30.9%) 14 (38.9%) 10 (27.0%)
Current smoker 6 (6.4%) 5 (13.9%) 1 (2.7%)
Alcohol (units/wk)   0.0 (0.0, 15.8) 3.0 (0.0, 20.0) 2.0 (0.0, 9.0)
Diagnosis TIA 40 (42.6%) 11 (30.6%) 10 (27.0%)
Stroke 54 (57.4%) 25 (69.4%) 27 (73.0%)
OCSP classification LACS 27 (50.0%) 9 (36.0%) 11 (40.7%)
PACS 13 (24.1%) 13 (52.0%) 11 (40.7%)
TACS 0 (0.0%) 0 (0.0%) 0 (0.0%)
POCS 14 (25.9%) 3 (12.0%) 5 (18.5)
Past medical history AF 25 (26.6%) 6 (16.7%) 10 (27.0%)
Diabetes 19 (20.2%) 7 (19.4%) 5 (13.5%)
IHD 11 (11.7%) 4 (11.1%) 6 (16.2%)
Stroke 44 (46.8%) 12 (33.3%) 21 (56.8%)
TIA 36 (38.3%) 6 (16.7%) 7 (18.9%)
Hypertension 53 (56.4%) 20 (55.6%) 25 (67.6%)
Rockwood Frailty Score   4.0 (3.0, 6.0) 5.0 (4.0, 6.0) 6.0 (4.5, 6.0)
MoCA   27.4 (1.4) 23.4 (1.4) 23.2 (1.5)
Clinic BP (mmHg) Systolic 147.3 (20.5) 148.1 (21.0) 145.2 (19.5)
Diastolic 79.6 (10.5) 78.9 (11.5) 81.8 (12.5)
Total Cholesterol (mmol/L)   4.9 (1.2) 4.9 (1.2) 4.6 (1.4)
Heart rate (beats per min)a   76.6 (18.9) 75.9 (16.8) 80.4 (10.2)
On anticoagulationa   10/25 (40.0%) 3/6 (50.0%) 3/10 (30.0%)
HbA1C (mmol/mol)b   52.5 (47.3, 69.5) 49.5 (43.0, 82.3) 73.0 (51.8, 106.3)
  1. Data presented are mean (SD), median (IQR), or frequency (%)
  2. aOnly those with AF
  3. bOnly those with diabetes